Annemijn P A Wierenga
6PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Apr 28, 2023
Zebrafish Patient-Derived Xenograft Model as a Preclinical Platform for Uveal Melanoma Drug Discovery.Jie Yin, Gangyin Zhao, Helen Kalirai
|Sep 10, 2021
LAG3 and Its Ligands Show Increased Expression in High-Risk Uveal Melanoma.Zahra Souri, Annemijn P A Wierenga, Wilma G M Kroes
|Aug 27, 2021
Expression of HDACs 1, 3 and 8 Is Upregulated in the Presence of Infiltrating Lymphocytes in Uveal Melanoma.Zahra Souri, Aart G Jochemsen, Annemijn P A Wierenga
|Aug 27, 2021
MiRNAs Correlate with HLA Expression in Uveal Melanoma: Both Up- and Downregulation Are Related to Monosomy 3.Zahra Souri, Annemijn P A Wierenga, Emine Kiliç
|Aug 27, 2021
In Uveal Melanoma, Angiopoietin-2 but Not Angiopoietin-1 Is Increased in High-Risk Tumors, Providing a Potential Druggable Target.Anna M W Ten Voorde, Annemijn P A Wierenga, Rogier J Nell
|Dec 15, 2020
HDAC Inhibition Increases HLA Class I Expression in Uveal Melanoma.Zahra Souri, Aart G Jochemsen, Mieke Versluis
Pageof 1
Frequent Collaborators
6 joint publications
Martine J Jager
4 joint publications
Zahra Souri
4 joint publications
Robert M Verdijk
2 joint publications
Pieter A van der Velden
2 joint publications
Aart G Jochemsen
1 joint publications
Mieke Versluis
1 joint publications
Erwin Brosens
1 joint publications
Stefan Böhringer
1 joint publications
Gregorius P M Luyten
1 joint publications
Michael Eikmans
